$20.59
Tyra Biosciences is a biotechnology business based in the US. Tyra Biosciences shares (TYRA) are listed on the NASDAQ and all prices are listed in US Dollars. Tyra Biosciences employs 49 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy Tyra Biosciences stock
How to buy Tyra Biosciences stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – TYRA. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Tyra Biosciences stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Tyra Biosciences stock price (NASDAQ: TYRA)
Use our graph to track the performance of TYRA stocks over time.Tyra Biosciences shares at a glance
Latest market close | $20.59 |
---|---|
52-week range | $10.38 - $24.25 |
50-day moving average | $19.95 |
200-day moving average | $16.96 |
Wall St. target price | $26.33 |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-1.70 |
Is it a good time to buy Tyra Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Tyra Biosciences price performance over time
Historical closes compared with the close of $20.59 from 2024-09-06
1 week (2024-08-30) | -9.53% |
---|---|
1 month (2024-08-07) | 5.59% |
3 months (2024-06-07) | 4.10% |
6 months (2024-03-07) | 5.59% |
1 year (2023-09-07) | 35.73% |
---|---|
2 years (2022-09-07) | 173.44% |
3 years (2021-09-03) | N/A |
5 years (2019-09-03) | N/A |
Tyra Biosciences financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -18.57% |
Return on equity TTM | -26.5% |
Profit margin | 0% |
Book value | $7.13 |
Market Capitalization | $1.2 billion |
TTM: trailing 12 months
Tyra Biosciences share dividends
We're not expecting Tyra Biosciences to pay a dividend over the next 12 months.
Tyra Biosciences share price volatility
Over the last 12 months, Tyra Biosciences's shares have ranged in value from as little as $10.38 up to $24.25. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tyra Biosciences's is 1.015. This would suggest that Tyra Biosciences's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
To put Tyra Biosciences's beta into context you can compare it against those of similar companies.
- BioNTech (BNTX.US): 0.231
- Harpoon Therapeutics (HARP.US): 2.098
- Aptevo Therapeutics (APVO.US): 5.172
Tyra Biosciences overview
Tyra Biosciences, Inc. , a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in Phase 1/2 clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in Phase 1 clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California. .
Frequently asked questions
What percentage of Tyra Biosciences is owned by insiders or institutions?Currently 4.665% of Tyra Biosciences shares are held by insiders and 98.511% by institutions. How many people work for Tyra Biosciences?
Latest data suggests 49 work at Tyra Biosciences. When does the fiscal year end for Tyra Biosciences?
Tyra Biosciences's fiscal year ends in December. Where is Tyra Biosciences based?
Tyra Biosciences's address is: 2656 State Street, Carlsbad, CA, United States, 92008 What is Tyra Biosciences's ISIN number?
Tyra Biosciences's international securities identification number is: US90240B1061
More guides on Finder
-
Options profit calculator
Use this calculator to quickly see potential outcomes of your options trades.
-
Best paper trading platforms to practice trading with fake money [2024]
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
-
7 best day trading platforms of 2024
These are the best day trading platforms, according to Finder’s comprehensive analysis.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
Trading for beginners: 11 best trading platforms to get started
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
5 best international stock brokers to invest in foreign assets
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
-
9 best discount brokers of 2024 for low-cost trading and investing
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
-
10 best brokerage accounts for buying stocks, options and more in 2024
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question